| NCT ID | NCT05546086 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Beijing Friendship Hospital |
| Condition | Non-Alcoholic Fatty Liver Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 8,103 participants |
| Start Date | 2022-04-18 |
| Primary Completion | 2032-04-18 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 8,103 participants in total. It began in 2022-04-18 with a primary completion date of 2032-04-18.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Metabolic associated fatty liver disease(MEFLD) is a major chronic liver disease that can lead to various adverse events, such as liver cancer, cardiovascular disease, and chronic kidney disease. The present community-based cohort study enrolls subjects who take health physical examinations at the sub-center outpatient department, Beijing Friendship Hospital. Investigators collect their baseline information, including demographic data, clinical history, physical examination, laboratory results, imageological examination, and so on. Follow-up surveys are conducted annually and the information collected is the same as the baseline. The outcome information, including cardiovascular disease, malignancy, liver cirrhosis, liver decompensation, liver transplantation, and all-cause mortality, are obtained by linking to the hospital discharge database and death registration system of Beijing. The primary aim of the study is to build a risk-stratified evaluation system for MAFLD through the cohort.
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older * Permanent residents in Beijing * Signing informed consent Exclusion Criteria: * No
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05546086 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Non-Alcoholic Fatty Liver Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05546086 currently recruiting?
Yes, NCT05546086 is actively recruiting participants. Contact the research team at youhong30@sina.com for enrollment information.
Where is the NCT05546086 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05546086 clinical trial?
NCT05546086 is sponsored by Beijing Friendship Hospital. The trial plans to enroll 8,103 participants.